- Report
- March 2025
- 381 Pages
Global
From €5164EUR$5,450USD£4,358GBP
- Drug Pipelines
- July 2024
- 80 Pages
Global
From €1895EUR$2,000USD£1,599GBP
- Clinical Trials
- April 2024
- 85 Pages
Global
From €1895EUR$2,000USD£1,599GBP
- Report
- November 2024
- 168 Pages
Global
From €2369EUR$2,500USD£1,999GBP
- Report
- May 2024
- 133 Pages
Global
From €6158EUR$6,499USD£5,197GBP
- Clinical Trials
- October 2024
- 292 Pages
Global
From €3269EUR$3,450USD£2,759GBP
- Report
- January 2022
- 200 Pages
Global
From €7107EUR$7,500USD£5,998GBP
- Report
- January 2022
- 60 Pages
Global
From €3743EUR$3,950USD£3,159GBP
- Report
- January 2022
- 200 Pages
Global
From €7107EUR$7,500USD£5,998GBP
- Report
- January 2022
- 60 Pages
Global
From €3743EUR$3,950USD£3,159GBP
- Report
- April 2023
- 116 Pages
Global
From €4501EUR$4,750USD£3,799GBP
- Report
- October 2023
- 180 Pages
Global
From €4264EUR$4,500USD£3,599GBP
- Report
- January 2023
- 236 Pages
Global
From €4738EUR$5,000USD£3,999GBP
- Report
- October 2023
- 90 Pages
Global
From €3500EUR$3,957USD£3,057GBP
- Report
- October 2024
- 98 Pages
Global
From €3500EUR$3,957USD£3,057GBP
- Report
- June 2022
- 86 Pages
Global
From €1895EUR$2,000USD£1,599GBP
- Report
- November 2021
- 620 Pages
Global
From €3790EUR$4,000USD£3,199GBP
- Report
- January 2022
- 205 Pages
Global
From €3517EUR$3,712USD£2,969GBP

The Shingles Drug market is a subset of the Infectious Diseases Drugs market. It is composed of drugs used to treat shingles, a viral infection caused by the varicella-zoster virus. Symptoms of shingles include a painful rash, blisters, fever, and fatigue. Treatment typically involves antiviral medications, such as acyclovir, valacyclovir, and famciclovir. These drugs can reduce the severity and duration of the infection, as well as reduce the risk of complications.
The Shingles Drug market is highly competitive, with a number of large pharmaceutical companies offering products. These include GlaxoSmithKline, Merck & Co., Pfizer, Novartis, and Sanofi. Additionally, there are several smaller companies that specialize in the development of shingles drugs, such as ViroPharma, Valeant Pharmaceuticals, and Cipla. Show Less Read more